{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T14:17:35Z","timestamp":1782742655727,"version":"3.54.5"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,15]],"date-time":"2026-02-15T00:00:00Z","timestamp":1771113600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T00:00:00Z","timestamp":1773705600000},"content-version":"vor","delay-in-days":30,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-40253-8","type":"journal-article","created":{"date-parts":[[2026,2,15]],"date-time":"2026-02-15T08:23:12Z","timestamp":1771143792000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Phenotypic drug resistance and genome sequencing based identified mutations linked to resistance in Mycobacterium tuberculosis isolated from extrapulmonary clinical specimens"],"prefix":"10.1038","volume":"16","author":[{"given":"Hilina","family":"Mollalign","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawit Hailu","family":"Alemayehu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalkidan","family":"Melaku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abaysew","family":"Ayele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawit","family":"Chala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Getu","family":"Diriba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bazezew","family":"Yenew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muluwork","family":"Getahun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bethlehem","family":"Adnew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shewki","family":"Moga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey Michael","family":"Collins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arash","family":"Ghodousi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dereje","family":"Beyene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kidist","family":"Bobosha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liya","family":"Wassie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,15]]},"reference":[{"key":"40253_CR1","unstructured":"World Health Organization(WHO), Global Tuberculosis Report. (2024)."},{"key":"40253_CR2","unstructured":"World Health Organization(WHO), Global Tuberculosis Report. (2025)."},{"key":"40253_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-024-01025-1","author":"M Farhat","year":"2024","unstructured":"Farhat, M. et al. Drug-resistant tuberculosis: a persistent global health concern. Nat. Rev. Microbiol. https:\/\/doi.org\/10.1038\/s41579-024-01025-1 (2024).","journal-title":"Nat. Rev. Microbiol."},{"key":"40253_CR4","unstructured":"World Health Organization, Global lists of high-burden countries for TB, multi-drug \/ rifampicin-resistant TB(MDR\/RR-TB), and TB\/HIV, 2021\u20132025. (2021)."},{"key":"40253_CR5","unstructured":"World Health Organization. Global Tuberculosis Report;2023."},{"key":"40253_CR6","unstructured":"World Health Organization. Global Tuberculosis Report;2022."},{"key":"40253_CR7","unstructured":"National Tuberculosis Research Roadmap 2022\u20132026 3rd edition, Ministry of Health Ethiopia, 2022."},{"key":"40253_CR8","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s12879-015-0846-7","volume":"15","author":"S Berg","year":"2015","unstructured":"Berg, S. et al. Investigation of the high rates of extrapulmonary tuberculosis in Ethiopia reveals no single driving factor and minimal evidence for zoonotic transmission of Mycobacterium Bovis infection. BMC Infect. Dis. 15, 112. https:\/\/doi.org\/10.1186\/s12879-015-0846-7 (2015).","journal-title":"BMC Infect. Dis."},{"key":"40253_CR9","doi-asserted-by":"publisher","first-page":"e0243945","DOI":"10.1371\/journal.pone.0243945","volume":"15","author":"B Arega","year":"2020","unstructured":"Arega, B. et al. Epidemiology and the diagnostic challenge of extra-pulmonary tuberculosis in a teaching hospital in Ethiopia. PLOS ONE. 15, e0243945. https:\/\/doi.org\/10.1371\/journal.pone.0243945 (2020).","journal-title":"PLOS ONE"},{"key":"40253_CR10","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1586\/14787210.2014.899900","volume":"12","author":"L Norbis","year":"2014","unstructured":"Norbis, L. et al. Challenges and perspectives in the diagnosis of extrapulmonary tuberculosis. Expert Rev. Anti-infective Therapy. 12, 633\u2013647. https:\/\/doi.org\/10.1586\/14787210.2014.899900 (2014).","journal-title":"Expert Rev. Anti-infective Therapy"},{"key":"40253_CR11","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1186\/s12879-023-08629-7","volume":"23","author":"A V\u012bksna","year":"2023","unstructured":"V\u012bksna, A. et al. Genotypic and phenotypic comparison of drug resistance profiles of clinical multidrug-resistant Mycobacterium tuberculosis isolates using whole genome sequencing in Latvia. BMC Infect. Dis. 23, 638. https:\/\/doi.org\/10.1186\/s12879-023-08629-7 (2023).","journal-title":"BMC Infect. Dis."},{"key":"40253_CR12","doi-asserted-by":"publisher","first-page":"dlac042","DOI":"10.1093\/jacamr\/dlac042","volume":"4","author":"PM Mbelele","year":"2022","unstructured":"Mbelele, P. M. et al. Whole genome sequencing-based drug resistance predictions of multidrug-resistant Mycobacterium tuberculosis isolates from Tanzania. JAC Antimicrob. Resist. 4, dlac042. https:\/\/doi.org\/10.1093\/jacamr\/dlac042 (2022).","journal-title":"JAC Antimicrob. Resist."},{"key":"40253_CR13","doi-asserted-by":"publisher","first-page":"e0153563","DOI":"10.1371\/journal.pone.0153563","volume":"11","author":"S Ahmad","year":"2016","unstructured":"Ahmad, S., Mokaddas, E., Al-Mutairi, N., Eldeen, H. S. & Mohammadi, S. Discordance across phenotypic and molecular methods for drug susceptibility testing of drug-Resistant Mycobacterium tuberculosis isolates in a low TB incidence country. PLOS ONE. 11, e0153563. https:\/\/doi.org\/10.1371\/journal.pone.0153563 (2016).","journal-title":"PLOS ONE"},{"key":"40253_CR14","unstructured":"Catalogue of mutations in Mycobacterium tuberculosis complex and their association with drug resistance, second edition. Geneva: World Health Organization. Licence: CC BY-NC-SA 3.0 IGO. (2023)."},{"key":"40253_CR15","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s12864-020-6577-1","volume":"21","author":"BZ Katale","year":"2020","unstructured":"Katale, B. Z. et al. Whole genome sequencing of Mycobacterium tuberculosis isolates and clinical outcomes of patients treated for multidrug-resistant tuberculosis in Tanzania. BMC Genom. 21, 174. https:\/\/doi.org\/10.1186\/s12864-020-6577-1 (2020).","journal-title":"BMC Genom."},{"key":"40253_CR16","doi-asserted-by":"publisher","unstructured":"Mollalign, H. et al. Epidemiology and clinicodemographic features of microbiologically confirmed and presumptive extrapulmonary tuberculosis in ethiopia: A multicenter study. IJID Reg. 100765 https:\/\/doi.org\/10.1016\/j.ijregi.2025.100765 (2025).","DOI":"10.1016\/j.ijregi.2025.100765"},{"key":"40253_CR17","unstructured":"Technical report on critical concentrations for drug. susceptibility testing of isoniazid and the rifamycins (rifampicin, rifabutin and rifapentine). Geneva: World Health Organization; (2021)."},{"key":"40253_CR18","unstructured":"World Health Organization. Technical Report on critical concentrations for drug susceptibility testing of medicines used in the treatment of drug-resistant tuberculosis, (2018)."},{"key":"40253_CR19","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1186\/1756-0500-6-561","volume":"6","author":"IN de Almeida","year":"2013","unstructured":"de Almeida, I. N., da Silva Carvalho, W., Rossetti, M. L., Costa, E. R. D. & de Miranda, S. S. Evaluation of six different DNA extraction methods for detection of Mycobacterium tuberculosis by means of PCR-IS6110: preliminary study. BMC Res. Notes. 6, 561. https:\/\/doi.org\/10.1186\/1756-0500-6-561 (2013).","journal-title":"BMC Res. Notes"},{"key":"40253_CR20","unstructured":"Qubit 4. 0 Fluorometer User Guide. Catalog Number Q33226. Publication Number MAN0017209. Revision D.0."},{"key":"40253_CR21","unstructured":"Illumina, D. N. A. Prep Reference Guide, Document#1000000025416v09,2020."},{"key":"40253_CR22","doi-asserted-by":"publisher","first-page":"2987","DOI":"10.1093\/bioinformatics\/btr509","volume":"27","author":"H Li","year":"2011","unstructured":"Li, H. A statistical framework for SNP calling, mutation discovery, association mapping and population genetical parameter Estimation from sequencing data. Bioinformatics 27, 2987\u20132993. https:\/\/doi.org\/10.1093\/bioinformatics\/btr509 (2011).","journal-title":"Bioinformatics"},{"key":"40253_CR23","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1183\/09031936.00089808","volume":"33","author":"S. Hofmann-Thiel","year":"2009","unstructured":"Hofmann-Thiel, S. et al. Mechanisms of heteroresistance to isoniazid and rifampin of Mycobacterium tuberculosis in Tashkent, Uzbekistan. Eur. Respir. J. 33, 368. https:\/\/doi.org\/10.1183\/09031936.00089808 (2009).","journal-title":"Eur. Respir. J."},{"key":"40253_CR24","doi-asserted-by":"publisher","first-page":"e5895","DOI":"10.7717\/peerj.5895","volume":"6","author":"T. A. Kohl","year":"2018","unstructured":"Kohl, T. A. et al. MTBseq: a comprehensive pipeline for whole genome sequence analysis of Mycobacterium tuberculosis complex isolates. Peer J. 6, e5895 https:\/\/doi.org\/10.7717\/peerj.5895 (2018).","journal-title":"Peer J."},{"key":"40253_CR25","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s13073-019-0650-x","volume":"11","author":"JE Phelan","year":"2019","unstructured":"Phelan, J. E. et al. Integrating informatics tools and portable sequencing technology for rapid detection of resistance to anti-tuberculous drugs. Genome Med. 11, 41. https:\/\/doi.org\/10.1186\/s13073-019-0650-x (2019).","journal-title":"Genome Med."},{"key":"40253_CR26","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","volume":"25","author":"H Li","year":"2009","unstructured":"Li, H. & Durbin, R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25, 1754\u20131760. https:\/\/doi.org\/10.1093\/bioinformatics\/btp324 (2009).","journal-title":"Bioinformatics"},{"key":"40253_CR27","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/s41598-023-27516-4","volume":"13","author":"G Napier","year":"2023","unstructured":"Napier, G., Campino, S., Phelan, J. E. & Clark, T. G. Large-scale genomic analysis of Mycobacterium tuberculosis reveals extent of target and compensatory mutations linked to multi-drug resistant tuberculosis. Sci. Rep. 13, 623. https:\/\/doi.org\/10.1038\/s41598-023-27516-4 (2023).","journal-title":"Sci. Rep."},{"key":"40253_CR28","doi-asserted-by":"publisher","first-page":"e0048523","DOI":"10.1128\/jcm.00485-23","volume":"61","author":"X Zhang","year":"2023","unstructured":"Zhang, X. et al. Genomic markers of drug resistance in Mycobacterium tuberculosis populations with minority variants. J. Clin. Microbiol. 61, e0048523. https:\/\/doi.org\/10.1128\/jcm.00485-23 (2023).","journal-title":"J. Clin. Microbiol."},{"key":"40253_CR29","doi-asserted-by":"crossref","unstructured":"Salaam-Dreyer, Z. et al. Rifampicin-Monoresistant Tuberculosis Is Not the Same as Multidrug-Resistant Tuberculosis: a Descriptive Study from Khayelitsha, South Africa. Antimicrob Agents Chemother 65, e00364\u201321 (2021).","DOI":"10.1128\/AAC.00364-21"},{"key":"40253_CR30","doi-asserted-by":"publisher","first-page":"2100783","DOI":"10.1183\/13993003.00783-2021","volume":"58","author":"A Van Deun","year":"2021","unstructured":"Van Deun, A. et al. Mycobacterium tuberculosis borderline RpoB mutations: emerging from the unknown. Eur. Respir. J. 58, 2100783. https:\/\/doi.org\/10.1183\/13993003.00783-2021 (2021).","journal-title":"Eur. Respir. J."},{"key":"40253_CR31","doi-asserted-by":"publisher","first-page":"2100783","DOI":"10.1183\/13993003.00783-2021","volume":"58","author":"TD Van Armand","year":"2021","unstructured":"Van Armand, T. D. Kya Jai Maug Aung, Mohamed Anwar Hossain, mourad Gumusboga, Willem Bram de Rijk, Sabira Tahseen, Bouke Catherine de Jong, Leen Rigouts. Mycobacterium tuberculosis borderline RpoB mutations: emerging from the unknown. Eur. Respir J. 58, 2100783. https:\/\/doi.org\/10.1183\/13993003.00783-2021 (2021).","journal-title":"Eur. Respir J."},{"key":"40253_CR32","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1128\/aac.48.4.1289-1294.2004","volume":"48","author":"DH Mariam","year":"2004","unstructured":"Mariam, D. H., Mengistu, Y., Hoffner, S. E. & Andersson, D. I. Effect of RpoB mutations conferring Rifampin resistance on fitness of Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 48, 1289\u20131294. https:\/\/doi.org\/10.1128\/aac.48.4.1289-1294.2004 (2004).","journal-title":"Antimicrob. Agents Chemother."},{"key":"40253_CR33","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.1126\/science.1124410","volume":"312","author":"S Gagneux","year":"2006","unstructured":"Gagneux, S. et al. The competitive cost of antibiotic resistance in Mycobacterium tuberculosis. Science 312, 1944\u20131946. https:\/\/doi.org\/10.1126\/science.1124410 (2006).","journal-title":"Science"},{"key":"40253_CR34","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/ng.1038","volume":"44","author":"I Comas","year":"2012","unstructured":"Comas, I. et al. Whole-genome sequencing of rifampicin-resistant Mycobacterium tuberculosis strains identifies compensatory mutations in RNA polymerase genes. Nat. Genet. 44, 106\u2013110. https:\/\/doi.org\/10.1038\/ng.1038 (2012).","journal-title":"Nat. Genet."},{"key":"40253_CR35","doi-asserted-by":"publisher","unstructured":"Conkle-Gutierrez, D. et al. Novel and reported compensatory mutations in RpoABC genes found in drug resistant tuberculosis outbreaks. Front. Microbiol. 14 https:\/\/doi.org\/10.3389\/fmicb.2023.1265390 (2024).","DOI":"10.3389\/fmicb.2023.1265390"},{"key":"40253_CR36","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/s41426-018-0101-6","volume":"7","author":"Q Liu","year":"2018","unstructured":"Liu, Q. et al. Have compensatory mutations facilitated the current epidemic of multidrug-resistant tuberculosis? Emerg. Microbes Infect. 7, 98. https:\/\/doi.org\/10.1038\/s41426-018-0101-6 (2018).","journal-title":"Emerg. Microbes Infect."},{"key":"40253_CR37","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1101\/gr.128678.111","volume":"22","author":"N Casali","year":"2012","unstructured":"Casali, N. et al. Microevolution of extensively drug-resistant tuberculosis in Russia. Genome Res. 22, 735\u2013745. https:\/\/doi.org\/10.1101\/gr.128678.111 (2012).","journal-title":"Genome Res."},{"key":"40253_CR38","doi-asserted-by":"publisher","first-page":"102091","DOI":"10.1016\/j.tube.2021.102091","volume":"129","author":"AK Alame Emane","year":"2021","unstructured":"Alame Emane, A. K., Guo, X., Takiff, H. E. & Liu, S. Drug resistance, fitness and compensatory mutations in Mycobacterium tuberculosis. Tuberculosis 129, 102091. https:\/\/doi.org\/10.1016\/j.tube.2021.102091 (2021).","journal-title":"Tuberculosis"},{"key":"40253_CR39","doi-asserted-by":"publisher","first-page":"e506","DOI":"10.1016\/s2666-5247(23)00110-6","volume":"4","author":"GA Goig","year":"2023","unstructured":"Goig, G. A. et al. Effect of compensatory evolution in the emergence and transmission of rifampicin-resistant Mycobacterium tuberculosis in cape Town, South africa: a genomic epidemiology study. Lancet Microbe. 4, e506\u2013e515. https:\/\/doi.org\/10.1016\/s2666-5247(23)00110-6 (2023).","journal-title":"Lancet Microbe"},{"key":"40253_CR40","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.meegid.2016.09.004","volume":"45","author":"AN Unissa","year":"2016","unstructured":"Unissa, A. N., Subbian, S., Hanna, L. E. & Selvakumar, N. Overview on mechanisms of Isoniazid action and resistance in Mycobacterium tuberculosis. Infect. Genet. Evol. 45, 474\u2013492. https:\/\/doi.org\/10.1016\/j.meegid.2016.09.004 (2016).","journal-title":"Infect. Genet. Evol."},{"key":"40253_CR41","unstructured":"World Health Organization, Global Tuberculosis Report. (2017)."},{"key":"40253_CR42","doi-asserted-by":"publisher","first-page":"e1003008","DOI":"10.1371\/journal.pmed.1003008","volume":"17","author":"AS Dean","year":"2020","unstructured":"Dean, A. S. et al. Prevalence and genetic profiles of Isoniazid resistance in tuberculosis patients: A multicountry analysis of cross-sectional data. PLoS Med. 17, e1003008. https:\/\/doi.org\/10.1371\/journal.pmed.1003008 (2020).","journal-title":"PLoS Med."},{"key":"40253_CR43","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12879-023-08909-2","volume":"24","author":"L Zhang","year":"2024","unstructured":"Zhang, L. et al. Treatment outcomes of retreated patients with isoniazid\/rifampicin resistant pulmonary tuberculosis. BMC Infect. Dis. 24, 7. https:\/\/doi.org\/10.1186\/s12879-023-08909-2 (2024).","journal-title":"BMC Infect. Dis."},{"key":"40253_CR44","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1080\/20477724.2021.1928870","volume":"116","author":"F Norouzi","year":"2022","unstructured":"Norouzi, F. et al. Significance of the coexistence of non-codon 315 katG, inhA, and oxyR-ahpC intergenic gene mutations among isoniazid-resistant and multidrug-resistant isolates of Mycobacterium tuberculosis: a report of novel mutations. Pathog Glob Health. 116, 22\u201329. https:\/\/doi.org\/10.1080\/20477724.2021.1928870 (2022).","journal-title":"Pathog Glob Health"},{"key":"40253_CR45","doi-asserted-by":"publisher","first-page":"e532","DOI":"10.1093\/cid\/ciaa254","volume":"71","author":"V Srinivasan","year":"2020","unstructured":"Srinivasan, V. et al. Sources of multidrug resistance in patients with previous Isoniazid-Resistant tuberculosis identified using whole genome sequencing: A longitudinal cohort study. Clin. Infect. Dis. 71, e532\u2013e539. https:\/\/doi.org\/10.1093\/cid\/ciaa254 (2020).","journal-title":"Clin. Infect. Dis."},{"key":"40253_CR46","doi-asserted-by":"publisher","first-page":"e00366","DOI":"10.1002\/rcr2.366","volume":"6","author":"J Gibson","year":"2018","unstructured":"Gibson, J., Donnan, E. & Eather, G. Management of rifampicin mono-resistant tuberculosis in Queensland, australia: a retrospective case series. Respirol. Case Rep. 6, e00366. https:\/\/doi.org\/10.1002\/rcr2.366 (2018).","journal-title":"Respirol. Case Rep."},{"key":"40253_CR47","doi-asserted-by":"publisher","first-page":"e0258295","DOI":"10.1371\/journal.pone.0258295","volume":"16","author":"G Diriba","year":"2021","unstructured":"Diriba, G. et al. Drug resistance and its risk factors among extrapulmonary tuberculosis in ethiopia: A systematic review and meta-analysis. PLOS ONE. 16, e0258295. https:\/\/doi.org\/10.1371\/journal.pone.0258295 (2021).","journal-title":"PLOS ONE"},{"key":"40253_CR48","doi-asserted-by":"publisher","first-page":"174","DOI":"10.4103\/ijmr.ijmr_607_22","volume":"157","author":"P Desikan","year":"2023","unstructured":"Desikan, P. et al. Heteroresistance to rifampicin & Isoniazid in clinical samples of patients with presumptive drug-resistant tuberculosis in central India. Indian J. Med. Res. 157, 174\u2013182. https:\/\/doi.org\/10.4103\/ijmr.ijmr_607_22 (2023).","journal-title":"Indian J. Med. Res."},{"key":"40253_CR49","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s12941-021-00478-z","volume":"20","author":"M Ye","year":"2021","unstructured":"Ye, M. et al. Antibiotic heteroresistance in Mycobacterium tuberculosis isolates: a systematic review and meta-analysis. Ann. Clin. Microbiol. Antimicrob. 20, 73. https:\/\/doi.org\/10.1186\/s12941-021-00478-z (2021).","journal-title":"Ann. Clin. Microbiol. Antimicrob."},{"key":"40253_CR50","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.ijregi.2021.12.007","volume":"2","author":"M Getahun","year":"2022","unstructured":"Getahun, M., Ameni, G., Mollalign, H., Diriba, G. & Beyene, D. Genotypic and phenotypic drug-resistance detection and prevalence of heteroresistance in patients with isoniazid- and multidrug-resistant tuberculosis in Ethiopia. IJID Reg. 2, 149\u2013153. https:\/\/doi.org\/10.1016\/j.ijregi.2021.12.007 (2022).","journal-title":"IJID Reg."},{"key":"40253_CR51","doi-asserted-by":"publisher","first-page":"14194","DOI":"10.1038\/s41598-021-93501-4","volume":"11","author":"AS Khan","year":"2021","unstructured":"Khan, A. S. et al. Characterization of rifampicin-resistant Mycobacterium tuberculosis in Khyber Pakhtunkhwa, Pakistan. Sci. Rep. 11, 14194. https:\/\/doi.org\/10.1038\/s41598-021-93501-4 (2021).","journal-title":"Sci. Rep."},{"key":"40253_CR52","doi-asserted-by":"publisher","unstructured":"Chen, X. et al. Evaluation of Whole-Genome sequence method to diagnose resistance of 13 Anti-tuberculosis drugs and characterize resistance genes in clinical Multi-Drug resistance Mycobacterium tuberculosis isolates from China. Front. Microbiol. 10\u20132019. https:\/\/doi.org\/10.3389\/fmicb.2019.01741 (2019).","DOI":"10.3389\/fmicb.2019.01741"},{"key":"40253_CR53","doi-asserted-by":"publisher","unstructured":"Ghodousi, A. et al. Evaluating the efficacy of whole genome sequencing in predicting susceptibility profiles for first-line antituberculosis drugs. Clin. Microbiol. Infect. 31 https:\/\/doi.org\/10.1016\/j.cmi.2024.09.024 (2025). 121.e121-121.e125.","DOI":"10.1016\/j.cmi.2024.09.024"},{"key":"40253_CR54","doi-asserted-by":"publisher","first-page":"e292","DOI":"10.1016\/S2666-5247(23)00007-1","volume":"4","author":"Y Chen","year":"2023","unstructured":"Chen, Y., Takiff, H. E. & Gao, Q. Phenotypic instability of Mycobacterium tuberculosis strains harbouring clinically prevalent drug-resistant mutations. Lancet Microbe. 4, e292. https:\/\/doi.org\/10.1016\/S2666-5247(23)00007-1 (2023).","journal-title":"Lancet Microbe"},{"key":"40253_CR55","doi-asserted-by":"publisher","first-page":"e019135","DOI":"10.1136\/bmjgh-2025-019135","volume":"10","author":"SB Georghiou","year":"2025","unstructured":"Georghiou, S. B. et al. Targeted next-generation sequencing for drug-resistant tuberculosis diagnosis: implementation considerations for bacterial load, regimen selection and diagnostic algorithm placement. BMJ Global Health. 10, e019135. https:\/\/doi.org\/10.1136\/bmjgh-2025-019135 (2025).","journal-title":"BMJ Global Health"},{"key":"40253_CR56","doi-asserted-by":"publisher","first-page":"e02087","DOI":"10.1128\/spectrum.02087-21","volume":"10","author":"W Wang","year":"2022","unstructured":"Wang, W. et al. Reevaluating rifampicin breakpoint concentrations for Mycobacterium tuberculosis isolates with Disputed\u2009<\u2009i>rpoB mutations and discordant susceptibility phenotypes. Microbiol. Spectr. 10, e02087\u2013e02021. https:\/\/doi.org\/10.1128\/spectrum.02087-21 (2022).","journal-title":"Microbiol. Spectr."},{"key":"40253_CR57","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.2147\/idr.S358301","volume":"15","author":"H Xia","year":"2022","unstructured":"Xia, H. et al. Detection of Mycobacterium tuberculosis rifampicin resistance conferred by borderline RpoB mutations: Xpert MTB\/RIF is superior to phenotypic drug susceptibility testing. Infect. Drug Resist. 15, 1345\u20131352. https:\/\/doi.org\/10.2147\/idr.S358301 (2022).","journal-title":"Infect. Drug Resist."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-40253-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-40253-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-40253-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T23:02:13Z","timestamp":1773788533000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-40253-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,15]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["40253"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-40253-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5302564\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,15]]},"assertion":[{"value":"21 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9160"}}